Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in youngsters and grown-ups . In Canada, its distribution is overseen by Health https://vyvansepharmacyincanada855752.jaiblogs.com/70295099/lisdexamfetamine-in-canada-a-comprehensive-guide